![Patient Authorship: Three Key Questions (& Answers!) for Medical Communication Professionals [Part B]](https://i0.wp.com/www.ismpp-newsletter.com/wp-content/uploads/2020/05/Overcoming-Challenges_cropped3_shutterstock_177184073.jpg?resize=999%2C675&ssl=1)
May 26, 2020 | News and Trends
Professor Karen L. Woolley. Envision Pharma Group, Australia; University of Queensland, Brisbane, Australia; University of the Sunshine Coast, Maroochydore, Australia.Professor Beverley Yamamoto. Osaka University, Osaka, Japan; Hereditary Angioedema Japan (Registered...
![Patient Authorship: Three Key Questions (& Answers!) for Medical Communication Professionals [Part A]](https://i0.wp.com/www.ismpp-newsletter.com/wp-content/uploads/2020/05/Benefits-Risks_shutterstock_296005736.jpg?resize=1000%2C562&ssl=1)
May 13, 2020 | News and Trends
Professor Karen L. Woolley. Envision Pharma Group, Australia; University of Queensland, Brisbane, Australia; University of the Sunshine Coast, Maroochydore, Australia.Professor Beverley Yamamoto. Osaka University, Osaka, Japan; Hereditary Angioedema Japan (Registered...
